Back

When the expierence surpasses evidence in pulmonar hypertension

11 May 2026 (09:30 - 10:15)
Organised by: Logo
Congress Presentation Part of: New insights into diagnostics and imaging in pulmonary vascular disease Pulmonary Hypertension HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Paul Enrique Vargas Mieles

Sanatorium of the Trinidad Quilmes, Buenos Aires (Argentina)

4 More presentations in this session

Presentation thumbnail
Using a large language model for echocardiographic identification of right ventricular dysfunction in patients with pulmonary hypertension
Doctor L. Ekambarapu (Durham, US)
Abstract Slides
Presentation thumbnail
Detection of right ventricular heart disease in patients with adult congenital heart disease using artificial intelligence assisted electrocardiogram interpretation
Mr D. Ahmetagic (Utrecht, NL)
Abstract Slides
Presentation thumbnail
Translational application of a self-organized deep feature engineering pipeline for non-invasive pulmonary hypertension classification from routine chest radiographs
Professor T. Kivrak (Elazig, TR)
Abstract Slides
Presentation thumbnail
Reduced DLCO flags early right-heart strain in systemic sclerosis despite short disease duration
Doctor T. Prata Branco (Porto, PT)
Abstract Slides

Access the full session

Session thumbnail
New insights into diagnostics and imaging in pulmonary vascular disease

The Event

Event poster

Heart Failure 2026

11 May 2026 09:30 CET
You may be interested in
thumbnail
Congress Presentation
Improving risk stratifcation of pulmonary hypertension patients
27 August 2021
thumbnail
Congress Presentation
TAPSE/systolic pulmonary artery pressure in patients with repaired TOF: Does it correlate with cardiac magnetic resonance indices?
10 May 2023
thumbnail
Congress Presentation
Pre-transplant right ventricle-to-pulmonary artery uncoupling on echocardiography and risk of early mortality after heart transplantation
11 May 2026
thumbnail
Congress Presentation
Real-life evidence of the use of subcutaneous treprostinil in pulmonary hypertension in Argentina
1 July 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources